Travel & Tourism Industry release:
HONG KONG, Jan. 31, 2018 /PRNewswire/ — Golden Meditech Holdings Limited (SEHK stock code: 00801) (the “Company”), a leading integrated healthcare enterprise in China, is pleased to announce that the sale of 65.4% of the issued share capital of China Cord Blood Corporation to Nanjing Yingpeng Huikang Medical Industry Investment Partnership (Limited Partnership)* has been completed.
Click here to read the full release with contact information on PR Newswire. Some releases are not in English.
To post and circulate your own press release on FIR and the eTN Network please click here
Comments are closed here.